Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, Opt-in with us: www.register.msviewsandnews.org

Please visit our MS learning channel on YouTube, which provides hundreds of MS topics presented by MS Experts across the USA, from many of our video recorded education programs. Archived here: www.youtube.com/msviewsandnews -- PLUS Visit our Social media platforms: Facebook, Twitter, and Instagram

~~ Left side of this blog shows resources, needed by many. Easiest way to find topic or articles is to use our 'search by topic' tool, to find specific information ~~

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Wednesday, April 25, 2018

Is the MRI Contrasting Agent Gadolinium Safe? (Part 1)

contrast






When a doctor orders an MRI with contrast, gadolinium is usually the contrasting agent used. Gadolinium is injected into the patient’s vein after the radiologist takes the first round of MRI images. This helps the radiologist receive sharper, more readable images.
In the case of multiple sclerosis (MS), the images taken with a contrasting agent highlight inflammation. The highlighted areas can show new or active lesions on the brain and the spine.
Gadolinium offers extra insight into our body’s condition. But is it safe? That question is part of a growing debate in the MS community.
Recent findings have shown that in some cases, the body can retain gadolinium in its tissues and brain for years.     - Continue Reading
                      
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

No comments: